Mary Crowley Cancer Research Center Announces Today Dendreon Corporation (DNDN)'s PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
4/17/2009 9:31:37 AM
More...
|
Mary Crowley Cancer Research Center Announces Today PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
4/17/2009 7:01:37 AM
More...
|
Champions Biotechnology, Inc. (CSBR) Partners with Gradalis Inc. and Mary Crowley Cancer Research Center to Develop Personalized Vaccines for Cancer Patients
2/3/2009 9:37:01 AM
More...
|